Pharmaceutical and healthcare digital advertising surged during the epidemic
As advertising increasingly moves online, pharma and healthcare are taking a bigger share. The industry is expected to spend more than $9.5 billion on digital media this year, according to research firm eMarketer.
The industry's growth rate of more than 14 percent puts it in second place, behind computing products and consumer electronics at 18 percent.
Although the pharmaceutical and healthcare industries have been slower to adopt digital marketing than other industries tracked by eMarketer, the epidemic has accelerated the growth of consumer and professional digital advertising in the sector, the researchers said.
eMarketer expects this trend to continue. By 2021, digital ad spending is expected to grow another 18 percent, to $11.3 billion.
Driving this year's marketing growth, eMarketer says, are digital marketing's pandemic messages on testing and security and related topics, including telemedicine, medical supplies and reopening doctor's offices.
In 2020, more than half (56%) of pharma and healthcare digital spend will be on search ads, with the rest going to display or banner ads.
Looking for chemical products? Let suppliers reach out to you!
2026-07-19
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Can an antibody 'cocktail' prevent COVID-19 infection?
-
McKinsey Pays to Close a Purdue Liability Chapter
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
Iran Conflict Leaves a Long Shadow on Drug Supply
-
Lilly Bets Bigger on China
-
Rising API Costs Threaten Drug Prices
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
Novo Nordisk Faces a Compliance Test
Recommend Reading
-
BioNTech’s Founders Turn the Page
-
India’s API Trade Balance Turns Positive
-
Small Pharma Firms Under Threat as Regulator Tightens Quality Norms
-
Vertex Shares Plunge 14.4 Percent After Pain Drug Trial Misses Key Target and Study Halt
-
Merck Nears Acquisition of Cidara to Strengthen Flu Prevention Arsenal
-
Lack of Clear Positive Guidance, Polyester Staple Fiber Prices Fluctuate Downward in September
-
September Methanol Market Trends Narrowly Consolidate
-
China's Phenol Market in September Rises First Then Falls
-
September Petrochemical Prices for Gasoline and Diesel Mostly Fluctuate
-
Strong Supply and Weak Demand Lead to Lower Dichloromethane Prices in China